切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2021, Vol. 07 ›› Issue (02): 169 -173. doi: 10.3877/cma.j.issn.2096-1537.2021.02.014

综述 上一篇    下一篇

脓毒症休克的诊治在精准医学时代下的发展及临床应用
张璐 1, 李响 1 , ( ), 夏世宏 1, 童琦 1, 孙英杰 1, 马雪丽 1   
  1. 1. 201199 上海,复旦大学附属闵行医院重症监护室
  • 收稿日期:2020-09-29 出版日期:2021-05-28
  • 通信作者: 李响

Development and clinical application of the diagnosis and treatment of septic shock in the era of precision medicine

Lu Zhang 1, Xiang Li 1 , ( ), Shihong Xia 1, Qi Tong 1, Yingjie Sun 1, Xueli. Ma 1   

  1. 1. Department of Intensive Care Unit, Minhang Hospital, Fudan University, Shanghai 201199, China
  • Received:2020-09-29 Published:2021-05-28
  • Corresponding author: Xiang Li

脓毒症休克病情凶险,致死率高。精准医学作为新型医学概念,其医疗模式影响了众多肿瘤及慢性病患者,也为脓毒症的精确诊治带来曙光。同时临床操作技术、基因检测、分子生物学的发展为脓毒症的精准诊治提供了数据和信息,通过对脓毒症患者不同病理生理状态、生物标志物、病原学、基因组学的分析与鉴定来进行个性化精准诊治。本文就精准医学在脓毒症休克诊治中取得的进展进行综述,并对这种新医疗模式的未来进行展望。

Septic shock is a critical condition with high mortality. Precision medicine as a new medical concept has affected cancer and chronic disease patients which also bring the hope for the accurate diagnosis and treatment in patients with sepsis. The development of clinical operation technology, gene detection and molecular biology provides data and information for the accurate diagnosis and treatment of sepsis, and promotes the progress and innovation of the diagnosis and treatment. Personalized and accurate management can be perfomed according to different pathophysiological status, biomarkers, etiology, genomics and other aspects. We review the progress of precision medicine in the diagnosis and treatment of sepsis, and prospects the future of this new medical model.

1
Collins FS, Varmus H. A new initiative on precision medicine [J]. N Engl J Med, 2015, 372(9): 793-795.
2
Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis [J]. JAMA, 2010, 304(16): 1787-1794.
3
Singer IM, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
4
Angus DC, Linde-zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [J]. Crit Care Med, 2001, 29(7): 1303-1310.
5
Head LW, Coopersmith CM. Evolution of sepsis management: from early goal-directed therapy to personalized care [J]. Adv Surg, 2016, 50(1): 221-234.
6
Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy [J]. J Intensive Care, 2017, 5: 51-57.
7
Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal [J]. Critical Care, 2020, 24(1): 287-301.
8
JäMSä J, Ala-Kokko T, Huotari V, et al. Neutrophil CD64, C-reactive protein, and procalcitonin in the identification of sepsis in the ICU - Post-test probabilities [J]. J Crit Care, 2018, 43:139-142.
9
Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research [J]. Lancet Infect Dis, 2015, 15(5), 581-614.
10
苏磊,徐秋林. 精准医学时代的脓毒症研究 [J]. 中华急诊医学杂志, 2016, 25(2): 133-138.
11
Fatani SH, Alkhatib KH, Badr H, et al. Association of TNF-α-308 (G >A) (rs1800629) gene polymorphism with adverse outcomes of sepsis in critically ill patients [J]. DNA Cell Biol, 2020, 39(9): 1723-1729.
12
Wu Q, Xu X, Ren J, et al. Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis [J]. BMC Anesthesiol, 2017, 17(1): 11.
13
Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults [J]. Crit Care Med, 2005, 33(3): 638-644.
14
Yende S, Angus DC, Kong L, et al. The influence of maemphage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia [J]. FASEB J, 2009, 23(8): 2403-2411.
15
Flores C, Ma SF, Maresso K, et al. IL6 gene-wide haplotype is associated with susceptibility to acute lung injury [J]. Transl Res, 2008, 152(1): 11-17.
16
Sutherland AM, Walley KR, Manocha S, et al. The association of interleukin 6 haplotype clades with mortality in critically ill adults [J]. Arch Intern Med, 2005, 165(1): 75-82.
17
Chen QX, Wu SJ, Wang HH, et al. Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population [J]. Hum Genet, 2008, 123(3): 281-287.
18
Russell JA, Wellman H, Walley KR. Protein C rs2069912 C allele is associated with increased mortality from severe sepsis in North Americans of East Asian ancestry [J]. Hum Genet, 2008, 123(6): 661-663.
19
Pachot A, Cazalis MA, Venet F, et al. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression [J]. J Immunol, 2008, 180(9): 6421-6429.
20
Johnson SB, Lissauer M, Bochicchio GV, et al. Gene expression profiles differentiate between sterile SIRS and early sepsis [J]. Ann Surg, 2007, 245(4): 611-621.
21
Liu L, Ning B. The role of MBL2 gene polymorphism in sepsis incidence [J]. Int J Clin Exp Pathol, 2015, 8(11): 15123-15127.
22
Middleton EA, Rowley JW, Campbell RA, et al. Sepsis alters the transcriptional and translational landscape of human and murine platelets [J]. Blood, 2019, 134(12): 911-923.
23
刘大为, 王小亭, 张宏民, 等. 重症血流动力学治疗-北京共识 [J]. 中华内科杂志, 2015, 54(3): 248-271.
24
王小亭, 刘大为, 张宏民, 等. 扩展的目标导向超声心动图方案对感染性休克患者的影响 [J]. 中华医学杂志, 201l, 91(27):1879-1883.
25
沈延飞, 蔡国龙. 脓毒症相关微循环障碍的研究进展 [J/OL]. 中华重症医学电子杂志, 2020, 6(2): 160-164.
26
Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis [J]. JAMA, 2019, 321(20): 2003-2017.
27
Roberts JA, Abdul-aziz MH, Lipman J. etal. Individualised antibiotic dosing for patients who are criticalill: challengs and potential solutions [J] Lancet Infect Dis, 2014, 14(6): 498-509.
28
黄英姿, 邱海波. 药代动力学导向的重症感染患者抗生素个体化与精准化治疗 [J]. 中华内科杂志, 2016, 55(6): 425-427.
29
Jiwaji Z, Brady S, Mcintyre LA, et al. Emergency department management of early sepsis: a national survey of emergency medicine and intensive care consultants [J]. Emerg Med J, 2014, 31(12): 1000-1005.
30
Spyridaki A, Raftogiannis M, Antonopoulou A, et al. Effect of elarithromycin in inflammatory inarkers of patients with ventilator-associated pneumonia and sepsis caused by gram-negative bacteria: Results from a randomized clinical study [J]. Antimicrob Agents Chemother, 2012, 56(7): 3819-3825.
31
Savva A, Kanni T, Damoraki G, et al. Impact of toll-like receptor-4 and turnout necrosis factor gene polymorphisms in patients with hidradenitis suppurativa [J]. Br J Dermatol, 2013, 168(2): 311-317.
32
肖桂珍, 李俊, 苏磊. 危重患者的精准营养 [J]. 中华危重病急救医学, 2017, 29(11): 1052-1056.
33
Committee on a Framework for Development a New Taxonomy of Disease, National Research Council. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease [M]. National Academies Press (US), 2011.
34
Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs [J]. JAMA. 2014, 311(19): 1998-2006.
[1] 王烁, 赵萍, 李秋洋, 张颖, 宋青, 朱嘉宁, 朱连华, 罗渝昆. 超声造影定量评价脓毒症急性肾损伤肾血流灌注及其参数与炎症因子的相关性[J]. 中华医学超声杂志(电子版), 2022, 19(01): 59-65.
[2] 赵继伟, 曾志芬, 曾红华, 张萌, 李玲玲, 何志捷, 植耀炜. 成人脓毒症患者骨髓细胞学特征的研究[J]. 中华危重症医学杂志(电子版), 2022, 15(01): 14-21.
[3] 冯娟, 吴先正, 王蒙蒙, 张海霞, 宋艳丽. 脓毒症合并胰腺损伤的危险因素及预后分析[J]. 中华危重症医学杂志(电子版), 2022, 15(01): 22-27.
[4] 康绍涛, 布祖克拉·阿布都艾尼, 李英杰, 拜合提尼沙·吐尔地. 体外膜肺氧合治疗脓毒症患者生存预后的Meta分析[J]. 中华危重症医学杂志(电子版), 2022, 15(01): 51-59.
[5] 曹杨, 刘瀚旻. 生物标志物在新生儿脓毒症中的应用研究进展[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(06): 643-649.
[6] 吴晓兰, 刘辉. 妊娠期生殖道感染所致产科脓毒症合并羊水栓塞分析并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(06): 685-691.
[7] 林巧, 王华. 血清presepsin(sCD14-ST)检测对新生儿败血症诊断价值的Meta分析[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(06): 699-708.
[8] 张锦鑫, 沈括, 胡大海, 尹文. 脓毒症早期诊断和治疗进展[J]. 中华损伤与修复杂志(电子版), 2022, 17(01): 76-80.
[9] 陈粹, 潘艳艳, 李吉良, 范友芬, 崔胜勇. 老年特重度烧伤合并脓毒症伴持续低体温的救治[J]. 中华损伤与修复杂志(电子版), 2021, 16(06): 503-508.
[10] 黄琴, 廖晓斌, 吴贵全. 急性生理与慢性健康Ⅱ评分联合血清降钙素原、D-二聚体、乳酸清除率预测重症脓毒症患者预后不良[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(06): 394-401.
[11] 郑少琴, 杨莎, 胡燕, 田青青. 脓毒性休克并发肺部感染及未分化结缔组织病一例[J]. 中华肺部疾病杂志(电子版), 2022, 15(01): 135-137.
[12] 赵云峰, 徐志华, 巫梦娜, 顾维立. 血清miR-133a在脓毒症并发ARDS中表达及预后的关系[J]. 中华肺部疾病杂志(电子版), 2022, 15(01): 38-41.
[13] 李向惠, 於江泉, 王晶. 脓毒症与铁代谢的研究进展[J]. 中华重症医学电子杂志, 2022, 08(01): 74-79.
[14] 王晶, 谭睿, 於江泉, 郑瑞强. 超声心动图在脓毒症心肌病中的应用进展[J]. 中华临床医师杂志(电子版), 2021, 15(06): 464-469.
[15] 孙同文. 脓毒症的发病机制及集束化治疗[J]. 中华卫生应急电子杂志, 2022, 08(01): 64-64.
阅读次数
全文


摘要